May 22, 2026 – In a significant paradigm shift for modern medicine, the class of drugs known as GLP-1 receptor agonists, already heralded as one of the most transformative medical breakthroughs in decades for their profound impact on weight management, has now revealed a compelling new dimension to their therapeutic potential. A sweeping new meta-a